Jasmine H. Francis

6.1k total citations · 1 hit paper
191 papers, 3.6k citations indexed

About

Jasmine H. Francis is a scholar working on Ophthalmology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jasmine H. Francis has authored 191 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 158 papers in Ophthalmology, 44 papers in Oncology and 38 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jasmine H. Francis's work include Ocular Oncology and Treatments (137 papers), Retinal Diseases and Treatments (24 papers) and Brain Metastases and Treatment (22 papers). Jasmine H. Francis is often cited by papers focused on Ocular Oncology and Treatments (137 papers), Retinal Diseases and Treatments (24 papers) and Brain Metastases and Treatment (22 papers). Jasmine H. Francis collaborates with scholars based in United States, Argentina and Netherlands. Jasmine H. Francis's co-authors include David H. Abramson, Brian P. Marr, Scott E. Brodie, Ira J. Dunkel, Y. Pierre Gobin, Richard D. Carvajal, Gary K. Schwartz, Paul Nathan, Tongalp H. Tezel and Paula Schaiquevich and has published in prestigious journals such as Nature, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Jasmine H. Francis

176 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Metastatic disease from uveal melanoma: treatment options and future prospects

2016 282 citations Brian P. Marr, Jasmine H. Francis et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jasmine H. Francis United States	32	2.4k	829	827	762	622	191	3.6k
Heinrich Heimann United Kingdom	37	3.7k 1.5×	630 0.8×	714 0.9×	2.4k 3.1×	252 0.4×	200	4.4k
Daniel C. Chung United States	24	885 0.4×	351 0.4×	2.5k 3.1×	366 0.5×	192 0.3×	73	3.4k
Jens Folke Kiilgaard Denmark	32	1.9k 0.8×	395 0.5×	1.3k 1.6×	817 1.1×	139 0.2×	140	3.0k
Anu Jacob United Kingdom	36	608 0.2×	420 0.5×	846 1.0×	253 0.3×	108 0.2×	104	8.0k
Nitza Goldenberg‐Cohen Israel	27	958 0.4×	233 0.3×	611 0.7×	351 0.5×	134 0.2×	122	1.9k
Arnold Munnich France	25	860 0.4×	88 0.1×	1.9k 2.3×	285 0.4×	203 0.3×	54	3.2k
Kenji Kitahara Japan	28	384 0.2×	746 0.9×	937 1.1×	223 0.3×	391 0.6×	150	2.5k
Robert Pilarski United States	28	347 0.1×	967 1.2×	1.8k 2.2×	61 0.1×	407 0.7×	62	3.6k
Giuseppe Broggi Italy	26	216 0.1×	303 0.4×	763 0.9×	184 0.2×	317 0.5×	184	2.2k
Tatsuo Hirose United States	30	1.5k 0.6×	135 0.2×	981 1.2×	1.4k 1.8×	229 0.4×	181	3.2k

Countries citing papers authored by Jasmine H. Francis

Since Specialization

Citations

This map shows the geographic impact of Jasmine H. Francis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jasmine H. Francis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jasmine H. Francis more than expected).

Fields of papers citing papers by Jasmine H. Francis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jasmine H. Francis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jasmine H. Francis. The network helps show where Jasmine H. Francis may publish in the future.

Co-authorship network of co-authors of Jasmine H. Francis

This figure shows the co-authorship network connecting the top 25 collaborators of Jasmine H. Francis. A scholar is included among the top collaborators of Jasmine H. Francis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jasmine H. Francis. Jasmine H. Francis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schram, Alison M., Alex A. Adjei, Anthony J. Olszanski, et al.. (2025). A phase I, first-in-human trial of KO-947, an ERK1/2 inhibitor, in patients with advanced solid tumors. ESMO Open. 10(3). 104300–104300.

Reingold, Rachel, Guilherme Harada, Andrea P. Moy, et al.. (2025). Mucocutaneous Adverse Events in Patients With Cancer Treated with the Highly Selective RET Kinase Inhibitor Selpercatinib (LOXO-292). JTO Clinical and Research Reports. 6(3). 100792–100792. 1 indexed citations

Francis, Jasmine H., et al.. (2024). Subfoveal Choroidal Thickness in Patients with Histiocytosis and Multimodal Imaging Features of Choroidal Infiltrates. Ophthalmology Retina. 9(6). 580–588.

Shen, Colette J., Stephen F. Kry, Jeffrey C. Buchsbaum, et al.. (2023). Retinopathy, Optic Neuropathy, and Cataract in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review. International Journal of Radiation Oncology*Biology*Physics. 119(2). 431–445. 10 indexed citations

Gobin, Y. Pierre, et al.. (2023). Advancements in super-selective catheterization and drug selection for intra-arterial chemotherapy for retinoblastoma: a 15-year evolution. Journal of NeuroInterventional Surgery. 16(4). 398–404. 8 indexed citations

Francis, Jasmine H., William Foulsham, James J. Harding, et al.. (2023). Mitogen-Activated Pathway Kinase Inhibitor-Associated Retinopathy: Do Features Differ with Upstream versus Downstream Inhibition?. Ocular Oncology and Pathology. 9(1-2). 25–31. 1 indexed citations

Foulsham, William, et al.. (2022). Central retinal vein occlusion in the setting of fibroblast growth factor receptor inhibition. American Journal of Ophthalmology Case Reports. 27. 101657–101657. 4 indexed citations

Pierce, Janene, Yuankai K. Tao, Sheau‐Chiann Chen, et al.. (2021). Intravitreal melphalan hydrochloride vs propylene glycol-free melphalan for retinoblastoma vitreous seeds: Efficacy, toxicity and stability in rabbits models and patients. Experimental Eye Research. 204. 108439–108439. 11 indexed citations

Bakhoum, Mathieu F., Jasmine H. Francis, Albert S. Agustinus, et al.. (2021). Loss of polycomb repressive complex 1 activity and chromosomal instability drive uveal melanoma progression. Nature Communications. 12(1). 5402–5402. 35 indexed citations

10.

Pichi, Francesco, Rosa Dolz‐Marco, Jasmine H. Francis, et al.. (2021). Advanced OCT Analysis of Biopsy-proven Vitreoretinal Lymphoma. American Journal of Ophthalmology. 238. 16–26. 24 indexed citations

11.

Wijsard, Milo van Hoefen, Sara J. Schonfeld, Flora E. van Leeuwen, et al.. (2021). Benign Tumors in Long-Term Survivors of Retinoblastoma. Cancers. 13(8). 1773–1773. 4 indexed citations

12.

Krebs, Simone, Audrey Mauguen, Onur Yıldırım, et al.. (2021). Prognostic value of [18F]FDG PET/CT in patients with CNS lymphoma receiving ibrutinib-based therapies. European Journal of Nuclear Medicine and Molecular Imaging. 48(12). 3940–3950. 12 indexed citations

13.

Francis, Jasmine H., et al.. (2020). Comparison of efficacy and toxicity of intravitreal melphalan formulations for retinoblastoma. PLoS ONE. 15(7). e0235016–e0235016. 8 indexed citations

14.

Francis, Jasmine H., Sofia Haque, Ira J. Dunkel, et al.. (2019). Magnetic Resonance Imaging Screening for Trilateral Retinoblastoma. Ophthalmology Retina. 4(3). 327–335. 10 indexed citations

15.

Francis, Jasmine H., et al.. (2017). Intraocular Pressure Changes Following Intravitreal Melphalan and Topotecan for the Treatment of Retinoblastoma with Vitreous Seeding. Europe PMC (PubMed Central). 3 indexed citations

16.

Francis, Jasmine H., David H. Abramson, Y. Pierre Gobin, et al.. (2015). Efficacy and Toxicity of Second-Course Ophthalmic Artery Chemosurgery for Retinoblastoma. Ophthalmology. 122(5). 1016–1022. 35 indexed citations

17.

Francis, Jasmine H., David H. Abramson, Y. Pierre Gobin, et al.. (2014). Electroretinogram Monitoring of Dose-Dependent Toxicity after Ophthalmic Artery Chemosurgery in Retinoblastoma Eyes: Six Year Review. PLoS ONE. 9(1). e84247–e84247. 40 indexed citations

18.

Daniels, Anthony B., Y. Pierre Gobin, Brian P. Marr, et al.. (2014). Intraarterial Chemotherapy (Ophthalmic Artery Chemosurgery) for Group D Retinoblastoma. Investigative Ophthalmology & Visual Science. 55(13). 3090–3090. 1 indexed citations

19.

Liu, Catherine Y., Jasmine H. Francis, Scott E. Brodie, et al.. (2014). RETINAL TOXICITIES OF CANCER THERAPY DRUGS. Retina. 34(7). 1261–1280. 48 indexed citations

20.

Francis, Jasmine H. & Paul Latkany. (2010). Intravitreal Methotrexate Use in Cystoid Macula Edema and Other Retinal Diseases: Lessons Learned From Intrathecal Administration. Investigative Ophthalmology & Visual Science. 51(13). 5870–5870. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact